<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02571179</url>
  </required_header>
  <id_info>
    <org_study_id>KUH12_04_2010</org_study_id>
    <nct_id>NCT02571179</nct_id>
  </id_info>
  <brief_title>Intranasal Fentanyl in Treatment of Labour Pain</brief_title>
  <acronym>fentaobs</acronym>
  <official_title>Intranasal Fentanyl in Treatment of Labour Pain - Efficacy and Safety</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Admescope Ltd</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Kuopio University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Physiological changes during pregnancy are known to affect the pharmacokinetics of many
      drugs. Intranasal fentanyl is an interesting option for obstetric analgesia, but its use in
      pregnant patients has not been established. The investigators studied pharmacokinetics of
      intranasal fentanyl in labouring women and to subsequently evaluate the maternal and fetal
      safety after administration.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Intranasal fentanyl</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fentanyl maximum concentration</measure>
    <time_frame>From the first intranasal fentanyl dose to birth of the newborn up to 48 hours</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>Intranasal fentanyl 50 microg/dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patient was given intranasal fentanyl 50 microg/dose up to 250 microg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intranasal fentanyl 50 microg dose up to 250 microg</intervention_name>
    <description>When contraction pain was ≥ 5/10 (numerical rating scale 0= no pain, 10= worst pain), the parturient was given a intranasal fentanyl 50 µg dose. After 15 minutes, if contraction pain was still ≥ 5/10, a second 50 µg intranasal dose was administered. Fentanyl was administered every 15 minute until contraction pain decreased to less than 5/10 or until the maximum fentanyl dose of 250 µg was administered.</description>
    <arm_group_label>Intranasal fentanyl 50 microg/dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy parturients with uncomplicated, single gestation pregnancies, full term (38-42
             weeks of gestation) pregnancy, agreed to participate

        Exclusion Criteria:

          -  a disease that might affect hepatic or renal function, contraindications to opioid
             analgesics, fetal growth retardation, signs of fetal asphyxia by cardiotocography,
             meconium stained amniotic fluid or placental insufficiency. The subjects should not
             have received fentanyl during the previous 14 days.

        Not agreed to participate
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merja Kokki, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kuopio University Hospital, Kuopio, Finland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Merja Kokki, PhD</last_name>
    <phone>+358447174764</phone>
    <email>merja.kokki@kuh.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <state>Northern savo</state>
        <zip>70029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Merja Kokki, PhD</last_name>
      <phone>+358447174764</phone>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2015</study_first_submitted>
  <study_first_submitted_qc>October 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2015</study_first_posted>
  <last_update_submitted>April 11, 2017</last_update_submitted>
  <last_update_submitted_qc>April 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kuopio University Hospital</investigator_affiliation>
    <investigator_full_name>Merja Kokki</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Labor pain</keyword>
  <keyword>Fentanyl</keyword>
  <keyword>Transmucosal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

